Research Reports

Key takeaways

Revenue increased 3% to $380K from $369K, driven by growth in spine-related products and OEM manufacturing demand.

Gross profit rose 17% to $144K with 37.9% margin, reflecting lower cost of revenue due to continued emphasis on higher-margin sales.

Operating loss expanded 35% to -$3.2M as G&A and sales/marketing costs rose from higher headcount and product launch activities.

Net loss increased 23% to -$2.8M, with diluted EPS improving 46% to -$0.70 from -$1.29.

Operating cash use rose to -$2.5M, reflecting investments in operations despite minimal $7K capex.

Going concern basis applied, with anticipated continued operating losses and cash usage despite expected 2026 revenue growth.

Full analysis

Revenue for the three months ended March 31, 2026 reached $380,000, up 3% from $369,000 in the prior year quarter. This growth stemmed from ongoing product lines and customer activities, particularly expansion in the Company’s spine-related product offerings and sustained demand in its OEM technical manufacturing business. Such dynamics highlight the resilience of core operations amid strategic shifts.

Cash flows from operating activities were -$2.5 million, up from -$1.3 million prior year, underscoring accelerated usage amid operational investments. Capital expenditures were minimal at $7,000, down sharply from $59,000. Liquidity remains a focus, with financial statements prepared on a going concern basis. Management anticipates ongoing operating losses and cash usage in operations, even as revenue is expected to increase throughout 2026 from Q1 recognition.

SINT · Sintx Technologies, Inc.

Summary

Key takeaways

Full analysis